Stocky
PODD
Insulet Corp.
NASDAQ NMS - GLOBAL MARKET · Health Care · US
133.26
▼ -20.12%

What's happening at Insulet Corp.

Insulet Corp.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 5 Aug 2026
Big update 5 Aug 2026

Second quarter 2026 earnings reported

Regular earnings updates help investors track if a company is growing and making money.

SEC 10-Q · filed 2026-08-05 View filing ↗
Earnings 5 Aug 2026

Second quarter 2026 earnings reported

Regular earnings updates help investors track if a company is growing and making money.

SEC 8-K · filed 2026-08-05 View filing ↗
People 25 Jun 2026

Jonathan Mazelsky joins board as director

New board members bring experience and oversight; Mazelsky led IDEXX as CEO from 2019 to 2026.

SEC 8-K · filed 2026-06-25 View filing ↗
Corporate 26 May 2026

Omnipod correction affects 7 million pods

Company expects up to $50 million in costs for this product correction but maintains 2026 guidance.

SEC 8-K · filed 2026-05-26 View filing ↗
Governance 21 May 2026

Board amends bylaws for Delaware forum rules

Rules changes clarify where shareholder lawsuits must be filed, affecting investor protections.

SEC 8-K · filed 2026-05-21 View filing ↗
Earnings 6 May 2026

First quarter 2026 earnings reported

Regular earnings updates help investors track if a company is growing and making money.

SEC 10-Q · filed 2026-05-06 View filing ↗
Earnings 6 May 2026

First quarter 2026 earnings reported

Regular earnings updates help investors track if a company is growing and making money.

SEC 8-K · filed 2026-05-06 View filing ↗

Common questions

How does Stocky track Insulet Corp.'s company events?

Stocky reads Insulet Corp.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Insulet Corp.'s most recent SEC filing?

Insulet Corp.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Second quarter 2026 earnings reported.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Insulet Corp.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.